Antimicrobial Stewardship from Health Professionals' Perspective : Awareness, Barriers, and Level of Implementation of the Program

This study aimed to evaluate health professionals' perceptions regarding the level of implementation of the Antimicrobials Stewardship (AMS) programs in Jordanian tertiary hospitals and to assess the perceived barriers to its implementation. During this cross-sectional study, a total of 157 healthcare providers agreed to participate (response rate 96.3%). Participants were asked to complete an electronic survey after meeting them at their working sites. Only 43.9% of the healthcare providers (n = 69) reported having an AMS committee in their hospital settings. The results suggested that private hospitals have significantly better AMS implementation compared to public hospitals among four areas (p ≤ 0.05). Moreover, the results showed that the most widely available strategies to implement AMS were infectious disease/microbiology advice (n = 112, 71.3%), and treatment guidelines (n = 111, 70.7%). Additionally, the study revealed that the main barrier to AMS implementation was the lack of information technology support (n = 125, 79.6%). These findings could draw managers' attention to the importance of AMS and support the health care provider's practice of AMS in Jordanian tertiary hospitals by making the right decisions and the required modifications regarding the strategies needed for the implementation of AMS programs.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

Antibiotics (Basel, Switzerland) - 11(2022), 1 vom: 14. Jan.

Sprache:

Englisch

Beteiligte Personen:

Nassar, Haya [VerfasserIn]
Abu-Farha, Rana [VerfasserIn]
Barakat, Muna [VerfasserIn]
Alefishat, Eman [VerfasserIn]

Links:

Volltext

Themen:

Antimicrobial stewardship
Jordan
Journal Article
Perception
Practice
Tertiary hospitals

Anmerkungen:

Date Revised 05.04.2024

published: Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.3390/antibiotics11010099

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM335876218